{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:02:12Z","timestamp":1757610132221,"version":"3.44.0"},"reference-count":23,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SJU"],"abstract":"<jats:p>Objective: To investigate the dose-dependent safety and efficacy of using Ethanol 99.5% as a sclerosing agent when treating hydro- and spermatoceles.\nMaterials and methods: This study (EUDRA-CT 2020-004630-38) was conducted as an open randomised multicentre study where symptomatic hydro- or spermatocele patients were randomised to sclerotherapy with 25- or 50-mL Ethanol 99.5%. The procedure was carried out at four Swedish outpatient clinics. An 8 F pigtail catheter was inserted after local anaesthetics of the skin, the fluid was drained and the randomised dose of Ethanol was instilled. After 30 min, the Ethanol was evacuated. Absorption was measured before and after instillation with a breathalyser and with a blood alcohol test before evacuation. Patients were followed-up by phone on days 1, 2, 3, 4, 30 and 90 after the procedure to capture any complications.\nResults: A total of 64 patients were included in this study. None had a significant absorption of alcohol (\u2265\u20090.2\u2030). The rate of complications was 18%. The number of serious complications needing intervention was 5%. The overall success rate, defined as light or no remaining discomfort, of the treatment regardless of dose was 79%. There was no difference between the different regimens with regards to complications and the success rate, but this study is underpowered in regard to those analysis.\nConclusions: No systemic absorption of Ethanol 99.5% occurred regardless of dose, when used as a sclerosing agent for hydro- and spermatoceles with a 79% cure rate. The efficacy and risks of complications are comparable to other sclerosants.<\/jats:p>","DOI":"10.2340\/sju.v60.44500","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:21:40Z","timestamp":1756905700000},"page":"180-185","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy in Sclerotherapy of testicular hydro\/spermatocele with 25 versus 50 mL Ethanol 99.5%; a randomised controlled phase II study"],"prefix":"10.2340","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6677-7056","authenticated-orcid":false,"given":"Sarah","family":"Velander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-1006","authenticated-orcid":false,"given":"Karl-Johan","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8455-2010","authenticated-orcid":false,"given":"Johan","family":"Styrke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"key":"125334","doi-asserted-by":"crossref","unstructured":"Lundstr\u00f6m KJ, S\u00f6derstr\u00f6m L, Jernow H, et al. Epidemiology of hydrocele and spermatocele; incidence, treatment and complications. Scand J Urol. 2019;53(2\u20133):134\u2013138. https:\/\/doi.org\/10.1080\/21681805.2019.1600582","DOI":"10.1080\/21681805.2019.1600582"},{"key":"125335","doi-asserted-by":"crossref","unstructured":"Itoh M, Li XQ, Miyamoto K, et al. Degeneration of the seminiferous epithelium with ageing is a cause of spermatoceles? Int J Androl. 1999;22(2):91\u201396. https:\/\/doi.org\/10.1046\/j.1365-2605.1999.00152.x","DOI":"10.1046\/j.1365-2605.1999.00152.x"},{"key":"125336","doi-asserted-by":"crossref","unstructured":"Shakiba B, Heidari K, Jamali A, et al. Aspiration and sclerotherapy versus hydrocoelectomy for treating hydrocoeles. Cochrane Database Syst Rev. 2014;11:CD009735. https:\/\/doi.org\/10.1002\/14651858.CD009735.pub2","DOI":"10.1002\/14651858.CD009735.pub2"},{"key":"125337","doi-asserted-by":"crossref","unstructured":"Hicks N, Gupta S. Complications and risk factors in elective benign scrotal surgery. Scand J Urol. 2016;50(6):468\u2013471. https:\/\/doi.org\/ 10.1080\/21681805.2016.1204622","DOI":"10.1080\/21681805.2016.1204622"},{"key":"125338","doi-asserted-by":"crossref","unstructured":"Swartz MA, Morgan TM, Krieger JN. Complications of scrotal surgery for benign conditions. Urology. 2007;69(4):616\u2013619. https:\/\/doi.org\/10.1016\/j.urology.2007.01.004","DOI":"10.1016\/j.urology.2007.01.004"},{"key":"125339","doi-asserted-by":"crossref","unstructured":"M\u00e4ki-Lohiluoma L, Kilpel\u00e4inen TP, J\u00e4rvinen P, et al. Risk of complications after hydrocele surgery: a retrospective multicenter study in Helsinki Metropolitan Area. Eur Urol Open Sci. 2022;43:22\u201327. https:\/\/doi.org\/10.1016\/j.euros.2022.06.008","DOI":"10.1016\/j.euros.2022.06.008"},{"key":"125340","doi-asserted-by":"crossref","unstructured":"Lund L, Kloster A, Cao T. The long-term efficacy of hydrocele treatment with aspiration and sclerotherapy with polidocanol compared to placebo: a prospective, double-blind, randomized study. J Urol. 2014;191(5):1347\u20131350. https:\/\/doi.org\/10.1016\/j.juro.2013.11.025","DOI":"10.1016\/j.juro.2013.11.025"},{"key":"125341","doi-asserted-by":"crossref","unstructured":"Jahnson S, Sandblom D, Holm\u00e4ng S. A randomized trial comparing 2 doses of polidocanol sclerotherapy for hydrocele or spermatocele. J Urol. 2011;186(4):1319\u20131323. https:\/\/doi.org\/10.1016\/j.juro.2011.06.005","DOI":"10.1016\/j.juro.2011.06.005"},{"key":"125342","doi-asserted-by":"crossref","unstructured":"Stattin P, Karlberg L, Damber JE. Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphate. Scand J Urol Nephrol. 1996;30(2):109\u2013113. https:\/\/doi.org\/10.3109\/00365599609180899","DOI":"10.3109\/00365599609180899"},{"key":"125343","doi-asserted-by":"crossref","unstructured":"Francis JJ, Levine LA. Aspiration and sclerotherapy: a nonsurgical treatment option for hydroceles. J Urol. 2013;189(5):1725\u20131729. https:\/\/doi.org\/10.1016\/j.juro.2012.11.008","DOI":"10.1016\/j.juro.2012.11.008"},{"key":"125344","doi-asserted-by":"crossref","unstructured":"Shan CJ, Lucon AM, Pagani R, et al. Sclerotherapy of hydroceles and spermatoceles with alcohol: results and effects on the semen analysis. Int Braz J Urol Off J Braz Soc Urol. 2011;37(3):307\u2013312; discussion 312\u2013333. https:\/\/doi.org\/10.1590\/S1677-55382011000300003","DOI":"10.1590\/S1677-55382011000300003"},{"key":"125345","doi-asserted-by":"crossref","unstructured":"Keller AK, Howard MM, Jensen JB. Complications after scrotal surgery \u2013 still a major issue? Scand J Urol. 2021;55(5):404\u2013407. https:\/\/doi.org\/10.1080\/21681805.2021.1884131","DOI":"10.1080\/21681805.2021.1884131"},{"key":"125346","doi-asserted-by":"crossref","unstructured":"Kiddoo DA, Wollin TA, Mador DR. A population based assessment of complications following outpatient hydrocelectomy and spermatocelectomy. J Urol. 2004;171(2 Pt 1):746\u2013748. https:\/\/doi.org\/10.1097\/01.ju.0000103636.61790.43","DOI":"10.1097\/01.ju.0000103636.61790.43"},{"key":"125347","doi-asserted-by":"crossref","unstructured":"Kairaluoma MI, Leinonen A, St\u00e5hlberg M, et al. Percutaneous aspiration and alcohol sclerotherapy for symptomatic hepatic cysts. An alternative to surgical intervention. Ann Surg. 1989;210(2):208\u2013215. https:\/\/doi.org\/10.1097\/00000658-198908000-00012","DOI":"10.1097\/00000658-198908000-00012"},{"key":"125348","doi-asserted-by":"crossref","unstructured":"Yonguc T, Sen V, Aydogdu O, et al. The comparison of percutaneous ethanol and polidocanol sclerotherapy in the management of simple renal cysts. Int Urol Nephrol. 2015;47(4):603\u2013607. https:\/\/doi.org\/10.1007\/s11255-015-0953-9","DOI":"10.1007\/s11255-015-0953-9"},{"key":"125349","doi-asserted-by":"crossref","unstructured":"Low LS, Nair SM, Davies AJW, et al. Aspiration and sclerotherapy of hydroceles and spermatoceles\/epididymal cysts with 100% alcohol. ANZ J Surg. 2020;90(1\u20132):57\u201361. https:\/\/doi.org\/10.1111\/ans.15467","DOI":"10.1111\/ans.15467"},{"key":"125350","doi-asserted-by":"crossref","unstructured":"Fr\u00e4nneby U, Gunnarsson U, Andersson M, et al. Validation of an Inguinal Pain Questionnaire for assessment of chronic pain after groin hernia repair. Br J Surg. 2008;95(4):488\u2013493. https:\/\/doi.org\/10.1002\/bjs.6014","DOI":"10.1002\/bjs.6014"},{"key":"125351","doi-asserted-by":"crossref","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"125352","doi-asserted-by":"crossref","unstructured":"Agrawal MS, Yadav H, Upadhyay A, et al. Sclerotherapy for hydrocele revisited: a prospective randomised study. Indian J Surg. 2009;71(1):23\u201328. https:\/\/doi.org\/10.1007\/s12262-009-0006-7","DOI":"10.1007\/s12262-009-0006-7"},{"key":"125353","doi-asserted-by":"crossref","unstructured":"Daehlin L, T\u00f8nder B, Kapstad L. Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst. Br J Urol. 1997;80(3):468\u2013471. https:\/\/doi.org\/10.1046\/j.1464-410X.1997.00358.x","DOI":"10.1046\/j.1464-410X.1997.00358.x"},{"key":"125354","doi-asserted-by":"crossref","unstructured":"Shan CJ, Lucon AM, Arap S. Comparative study of sclerotherapy with phenol and surgical treatment for hydrocele. J Urol. 2003;169(3):1056\u20131059. https:\/\/doi.org\/10.1097\/01.ju.0000052680.03705.40","DOI":"10.1097\/01.ju.0000052680.03705.40"},{"key":"125355","doi-asserted-by":"crossref","unstructured":"Karcioglu O, Topacoglu H, Dikme O, et al. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36(4):707\u2013714. https:\/\/doi.org\/10.1016\/j.ajem.2018.01.008","DOI":"10.1016\/j.ajem.2018.01.008"},{"key":"125356","doi-asserted-by":"crossref","unstructured":"Gerbershagen HJ, Rothaug J, Kalkman CJ, et al. Determination of moderate-to-severe postoperative pain on the numeric rating scale: a cut-off point analysis applying four different methods. Br J Anaesth. 2011;107(4):619\u2013626. https:\/\/doi.org\/10.1093\/bja\/aer195","DOI":"10.1093\/bja\/aer195"}],"container-title":["Scandinavian Journal of Urology"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/44500\/51302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/download\/44500\/51302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T13:21:47Z","timestamp":1756905707000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/SJU\/article\/view\/44500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":23,"URL":"https:\/\/doi.org\/10.2340\/sju.v60.44500","relation":{},"ISSN":["2168-1813"],"issn-type":[{"type":"electronic","value":"2168-1813"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}